Literature DB >> 19573813

Latent bone metastasis in breast cancer tied to Src-dependent survival signals.

Xiang H-F Zhang1, Qiongqing Wang, William Gerald, Clifford A Hudis, Larry Norton, Marcel Smid, John A Foekens, Joan Massagué.   

Abstract

Metastasis may arise years after removal of a primary tumor. The mechanisms allowing latent disseminated cancer cells to survive are unknown. We report that a gene expression signature of Src activation is associated with late-onset bone metastasis in breast cancer. This link is independent of hormone receptor status or breast cancer subtype. In breast cancer cells, Src is dispensable for homing to the bones or lungs but is critical for the survival and outgrowth of these cells in the bone marrow. Src mediates AKT regulation and cancer cell survival responses to CXCL12 and TNF-related apoptosis-inducing ligand (TRAIL), factors that are distinctively expressed in the bone metastasis microenvironment. Breast cancer cells that lodge in the bone marrow succumb in this environment when deprived of Src activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19573813      PMCID: PMC2749247          DOI: 10.1016/j.ccr.2009.05.017

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  56 in total

1.  Methods for assessing reproducibility of clustering patterns observed in analyses of microarray data.

Authors:  Lisa M McShane; Michael D Radmacher; Boris Freidlin; Ren Yu; Ming-Chung Li; Richard Simon
Journal:  Bioinformatics       Date:  2002-11       Impact factor: 6.937

Review 2.  Targeting death and decoy receptors of the tumour-necrosis factor superfamily.

Authors:  Avi Ashkenazi
Journal:  Nat Rev Cancer       Date:  2002-06       Impact factor: 60.716

3.  Dormancy of mammary carcinoma after mastectomy.

Authors:  T G Karrison; D J Ferguson; P Meier
Journal:  J Natl Cancer Inst       Date:  1999-01-06       Impact factor: 13.506

4.  Involvement of chemokine receptors in breast cancer metastasis.

Authors:  A Müller; B Homey; H Soto; N Ge; D Catron; M E Buchanan; T McClanahan; E Murphy; W Yuan; S N Wagner; J L Barrera; A Mohar; E Verástegui; A Zlotnik
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

Review 5.  Basic mechanisms responsible for osteolytic and osteoblastic bone metastases.

Authors:  Theresa A Guise; Khalid S Mohammad; Gregory Clines; Elizabeth G Stebbins; Darren H Wong; Linda S Higgins; Robert Vessella; Eva Corey; Susan Padalecki; Larry Suva; John M Chirgwin
Journal:  Clin Cancer Res       Date:  2006-10-15       Impact factor: 12.531

6.  Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.

Authors:  C M Perou; S S Jeffrey; M van de Rijn; C A Rees; M B Eisen; D T Ross; A Pergamenschikov; C F Williams; S X Zhu; J C Lee; D Lashkari; D Shalon; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

Review 7.  The role(s) of Src kinase and Cbl proteins in the regulation of osteoclast differentiation and function.

Authors:  William C Horne; Archana Sanjay; Angela Bruzzaniti; Roland Baron
Journal:  Immunol Rev       Date:  2005-12       Impact factor: 12.988

Review 8.  The CXCL12-CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapies.

Authors:  Richard J Epstein
Journal:  Nat Rev Cancer       Date:  2004-11       Impact factor: 60.716

9.  Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer.

Authors:  Nikolas H Stoecklein; Stefan B Hosch; Martin Bezler; Franziska Stern; Claudia H Hartmann; Christian Vay; Annika Siegmund; Peter Scheunemann; Paulus Schurr; Wolfram T Knoefel; Pablo E Verde; Uta Reichelt; Andreas Erbersdobler; Roger Grau; Axel Ullrich; Jakob R Izbicki; Christoph A Klein
Journal:  Cancer Cell       Date:  2008-05       Impact factor: 31.743

10.  HER2 and response to paclitaxel in node-positive breast cancer.

Authors:  Daniel F Hayes; Ann D Thor; Lynn G Dressler; Donald Weaver; Susan Edgerton; David Cowan; Gloria Broadwater; Lori J Goldstein; Silvana Martino; James N Ingle; I Craig Henderson; Larry Norton; Eric P Winer; Clifford A Hudis; Matthew J Ellis; Donald A Berry
Journal:  N Engl J Med       Date:  2007-10-11       Impact factor: 91.245

View more
  334 in total

1.  A HIF-regulated VHL-PTP1B-Src signaling axis identifies a therapeutic target in renal cell carcinoma.

Authors:  Natsuko Suwaki; Elsa Vanhecke; Katelyn M Atkins; Manuela Graf; Katherine Swabey; Paul Huang; Peter Schraml; Holger Moch; Amy Mulick Cassidy; Daniel Brewer; Bissan Al-Lazikani; Paul Workman; Johann De-Bono; Stan B Kaye; James Larkin; Martin E Gore; Charles L Sawyers; Peter Nelson; Tomasz M Beer; Hao Geng; Lina Gao; David Z Qian; Joshi J Alumkal; Gary Thomas; George V Thomas
Journal:  Sci Transl Med       Date:  2011-06-01       Impact factor: 17.956

2.  CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone.

Authors:  Véronique Ouellet; Kerstin Tiedemann; Anna Mourskaia; Jenna E Fong; Danh Tran-Thanh; Eitan Amir; Mark Clemons; Bernard Perbal; Svetlana V Komarova; Peter M Siegel
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

3.  The ubiquitin E3 ligase WWP1 decreases CXCL12-mediated MDA231 breast cancer cell migration and bone metastasis.

Authors:  Kristina Subik; Lei Shu; Chengyu Wu; Qianqian Liang; David Hicks; Brendan Boyce; Linda Schiffhauer; Di Chen; Ceshi Chen; Ping Tang; Lianping Xing
Journal:  Bone       Date:  2012-01-11       Impact factor: 4.398

4.  Novel roles for the E3 ubiquitin ligase atrophin-interacting protein 4 and signal transduction adaptor molecule 1 in G protein-coupled receptor signaling.

Authors:  Rohit Malik; Unice J K Soh; JoAnn Trejo; Adriano Marchese
Journal:  J Biol Chem       Date:  2012-01-24       Impact factor: 5.157

5.  Deriving transcriptional programs and functional processes from gene expression databases.

Authors:  Jeffrey T Chang
Journal:  Bioinformatics       Date:  2012-03-08       Impact factor: 6.937

Review 6.  Cell-matrix interactions in mammary gland development and breast cancer.

Authors:  John Muschler; Charles H Streuli
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-08-11       Impact factor: 10.005

Review 7.  Modeling metastasis in the mouse.

Authors:  Paula D Bos; Don X Nguyen; Joan Massagué
Journal:  Curr Opin Pharmacol       Date:  2010-07-01       Impact factor: 5.547

8.  Role for transcription factor TFII-I in the suppression of SSeCKS/Gravin/Akap12 transcription by Src.

Authors:  Yahao Bu; Lingqiu Gao; Irwin H Gelman
Journal:  Int J Cancer       Date:  2011-04-15       Impact factor: 7.396

Review 9.  Preclinical development of molecular-targeted agents for cancer.

Authors:  Alberto Ocana; Atanasio Pandiella; Lillian L Siu; Ian F Tannock
Journal:  Nat Rev Clin Oncol       Date:  2010-12-07       Impact factor: 66.675

10.  S100A14, a member of the EF-hand calcium-binding proteins, is overexpressed in breast cancer and acts as a modulator of HER2 signaling.

Authors:  Chengshan Xu; Hongyan Chen; Xiang Wang; Jidong Gao; Yiqun Che; Yi Li; Fang Ding; Aiping Luo; Shuguang Zhang; Zhihua Liu
Journal:  J Biol Chem       Date:  2013-11-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.